RJ Biotech Ltd. said its normalized net income for the fiscal first quarter ended June 30 came to 1.64 Indian rupees per share, a gain of 32.7% from 1.23 rupees per share in the prior-year period.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 15.5 million rupees, a gain from 4.4 million rupees in the year-earlier period.
The normalized profit margin increased to 8.8% from 4.4% in the year-earlier period.
Total revenue climbed 75.8% year over year to 176.1 million rupees from 100.2 million rupees, and total operating expenses grew 63.4% year over year to 142.7 million rupees from 87.4 million rupees.
Reported net income rose year over year to 24.8 million rupees, or 2.62 rupees per share, from 7.0 million rupees, or 1.98 rupees per share.
As of Aug. 11, US$1 was equivalent to 61.19 Indian rupees.
